Phase 1 Advanced Solid Tumor (Phase 1) Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
Advanced Solid Tumor (Phase 1)
Epics Therapeutics48 enrolled11 locationsNCT07163325
Recruiting
Phase 1
An Initial Evaluation of AN8025 in Solid Tumors
Advanced Solid Tumor (Phase 1)
Adlai Nortye Biopharma Co., Ltd.91 enrolled1 locationNCT07639047
Recruiting
Phase 1
A Phase I Study of JLM019 Injection
Hodgkin LymphomaNon-Hodgkin LymphomaAdvanced Solid Tumor (Phase 1)
Jecho Biopharmaceuticals Co., Ltd.115 enrolled1 locationNCT07623850
Recruiting
Phase 1
A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Advanced Solid CancerAdvanced Solid Tumor (Phase 1)
Aptabio Therapeutics, Inc.110 enrolled3 locationsNCT07123415